301033.SZ
Medprin Regenerative Medical Technologies Co., Ltd.
SZSE · C 制造业 · CN
CNY 53.76
+3.50%Margins
Gross margin
79.9%
EBITDA margin
41.6%
EBIT margin
33.0%
Net margin
29.4%
FCF margin
23.2%
13.4%
Return on equity
12.1%
Return on assets
14.9%
Return on invested capital
0.41x
Asset turnover
CNY 113.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026